HIF3A and neoplasm: In gastric cancer, HAND2-AS1 could inhibit the glycolytic process induced by hypoxia through miR-184/HIF3A signaling.[15] Taken together, the above evidence strongly supports that HAND2-AS1 may play a tumor suppressor role in human cancers.